title: Ten-year experience using an articulating antibiotic cement hip spacer for the treatment of chronically infected total hip.
abstract: Infection is a devastating complication after total-hip arthroplasty. Between June 1991 and December 2001, 42 patients were treated at our center for chronically infected total-hip arthroplasty using a 2-stage articulating antibiotic hip spacer technique. Of the 27 patients available for review, 26 (94%) remain clinically free of infection at an average 76 months (range, 28-148 months) postoperatively. Twenty-two (81%) patients had a positive identification of the infecting organism. All patients received a minimum of 6 weeks of intravenous antibiotics and the Harris Hip Scores improved from 53 (range, 36-68) to 92 (range, 81-99) postoperatively. Advantages of this technique include improved patient function, maintenance of bone stock and soft tissue tension, thus simplifying reimplantation.
authors.affiliation: Department of Orthopedics, University of Utah, Salt Lake City, USA.
authors.forename: Aaron A
authors.initials: AA
authors.lastname: Hofmann
authors.forename: Tyler D
authors.initials: TD
authors.lastname: Goldberg
authors.forename: Amie M
authors.initials: AM
authors.lastname: Tanner
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Cook
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001843:Bone Cements; D016503:Drug Delivery Systems; D005260:Female; D006622:Hip Prosthesis / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016459:Prosthesis-Related Infections / Q000188:drug therapy*; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D001843:Bone Cements